Actively Recruiting
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Led by University of Oklahoma · Updated on 2025-12-17
420
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
Sponsors
U
University of Oklahoma
Lead Sponsor
G
Gilead Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.
CONDITIONS
Official Title
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically or cytologically confirmed breast or prostate cancer
- 18 years of age or older
- African American race, Native American race, or Hispanic ethnicity
- Scheduled to undergo radiation therapy for cancer treatment
- Ability and willingness to sign informed consent
You will not qualify if you...
- Not African American, Native American, or Hispanic ethnicity
- No confirmed breast or prostate cancer diagnosis
- Younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States, 73117
Actively Recruiting
Research Team
L
Lead Onco Nurse
CONTACT
S
Shearwood McClelland III, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here